Your browser doesn't support javascript.
loading
A Phase IIIb Open-Label, Single-Arm Study of Afatinib in EGFR TKI-Naïve Patients with EGFRm+ NSCLC: Final Analysis, with a Focus on Patients Enrolled at Sites in China.
Tu, Hai-Yan; Feng, Jifeng; Shi, Meiqi; Zhao, Jun; Wang, Yuyan; Chang, Jianhua; Wang, Jialei; Cheng, Ying; Zhu, Jing; Tan, Eng-Huat; Li, Kai; Zhang, Yiping; Lee, Victor; Yang, Cheng-Ta; Su, Wu-Chou; Lam, David Chi-Leung; Srinivasa, B J; Rajappa, Senthil; Ho, Ching-Liang; Lam, Kwok Chi; Hu, Yi; Bondarde, Shailesh Arjun; Liu, Xiaoqing; Tian, Yahui; Xue, Zhiyi; Cseh, Agnieszka; Huang, Dennis Chin-Lun; Zhou, Caicun; Wu, Yi-Long.
Afiliação
  • Tu HY; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital and Guangdong Academy of Medical Sciences, Guangzhou, 510080, China.
  • Feng J; Department of Medical Oncology, Jiangsu Cancer Hospital and Jiangsu Institute of Cancer Research and The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, 210029, China.
  • Shi M; Department of Medical Oncology, Jiangsu Cancer Hospital and Jiangsu Institute of Cancer Research and The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, 210029, China.
  • Zhao J; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department 1 of Thoracic Oncology Medicine, Peking University Cancer Hospital and Institute, Beijing, 100142, China.
  • Wang Y; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department 1 of Thoracic Oncology Medicine, Peking University Cancer Hospital and Institute, Beijing, 100142, China.
  • Chang J; Fudan University Shanghai Cancer Center, Shanghai, 200032, China.
  • Wang J; Fudan University Shanghai Cancer Center, Shanghai, 200032, China.
  • Cheng Y; Division of Thoracic Oncology, Jilin Province Cancer Hospital, Changchun, 130012, China.
  • Zhu J; Division of Thoracic Oncology, Jilin Province Cancer Hospital, Changchun, 130012, China.
  • Tan EH; Department of Medical Oncology, National Cancer Centre, Singapore, 169610, Singapore.
  • Li K; Tianjin Medical University Cancer Institute and Hospital, Tianjin, 300060, China.
  • Zhang Y; Zhejiang Cancer Hospital, Hangzhou, 310022, China.
  • Lee V; Department of Clinical Oncology, Queen Mary Hospital, The University of Hong Kong, Hong Kong, China.
  • Yang CT; Clinical Oncology Center, The University of Hong Kong-Shenzhen Hospital, Shenzhen, 518053, China.
  • Su WC; Department of Thoracic Medicine, Linkou Chang Gung Memorial Hospital, Taoyuan, 333, Taiwan.
  • Lam DC; National Cheng Kung University Hospital, Tainan, 704, Taiwan.
  • Srinivasa BJ; Departments of Clinical Oncology, and Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong, China.
  • Rajappa S; HCG Hospital, Bangalore, 560020, India.
  • Ho CL; Basavatarakam Indo-American Cancer Hospital and Research Institute, Hyderabad, 500034, India.
  • Lam KC; Division of Hematology/Oncology, Tri-Service General Hospital, National Defense Medical Center, Taipei, 114, Taiwan.
  • Hu Y; Prince of Wales Hospital, Shatin, New Territories, Hong Kong, China.
  • Bondarde SA; Department of Oncology, Chinese PLA General Hospital, Beijing, 100853, China.
  • Liu X; Shatabdi Superspeciality Hospital, Nashik, 422005, India.
  • Tian Y; 307th Hospital of PLA, Beijing, 100070, China.
  • Xue Z; Boehringer Ingelheim (China) Investment Co., Ltd, Shanghai, China.
  • Cseh A; Boehringer Ingelheim (China) Investment Co., Ltd, Shanghai, China.
  • Huang DC; Boehringer Ingelheim International GmbH, 55216, Ingelheim, Germany.
  • Zhou C; Boehringer Ingelheim Taiwan Limited, Taipei, 104, Taiwan.
  • Wu YL; Shanghai Pulmonary Hospital, Tongji University, Shanghai, 200433, China.
Target Oncol ; 17(1): 1-13, 2022 01.
Article em En | MEDLINE | ID: mdl-35020119

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares Tipo de estudo: Clinical_trials / Observational_studies Limite: Aged / Humans Idioma: En Revista: Target Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China País de publicação: França

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares Tipo de estudo: Clinical_trials / Observational_studies Limite: Aged / Humans Idioma: En Revista: Target Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China País de publicação: França